by admin | Jun 2, 2023 | Health Awareness
If you’re struggling with health issues related to stress or other lifestyle difficulties, a support group might be able to help.
Support groups create an environment with other individuals who are experiencing similar, if not exact, circumstances. Support groups offer an opportunity to meet with other people who have similar problems, feelings, worries, or treatment side effects.
Here are some of the main benefits of participating in a support group.
You Feel Less Lonely
Diseases, injuries, and chronic pain can make you feel isolated, especially when no one around you has gone through what you’re going through.
Support groups can help alleviate feelings of loneliness by bringing you into a community with others who do know what you’re experiencing.
Reduced Symptoms of Anxiety and Depression
Feeling less lonely results in reduced symptoms of anxiety and depression. Support groups give you the opportunity to feel seen and understood, which can help minimize negative mental health symptoms like anxiety and depression.
Learn Different Coping Skills
Everyone has a different approach to managing difficulties in life. You will likely learn about new coping skills that can help you manage your problems.
Coping skills won’t make your challenges go away, but they help you self-manage your response in a healthier way.
Stay Motivated
Support groups can help you stay motivated to tackle the underlying causes of your chronic conditions. They can also encourage you to stick to your treatment plans, even if those plans are challenging.
Improve Your Understanding
Sharing in support groups can also help you better understand your condition and how it affects your life. Seeing things through the perspective of others adds dimension to how you view your condition.
Feel Empowered
Finally, support groups can help you feel empowered. They may offer a sense of hope or enhanced control over your life and conditions.
If you’ve felt lost or alone living with a chronic condition, try a support group near you.
by admin | May 31, 2023 | Stem Cell Therapy, Regenerative Medicine
Neuropathic pain (NP) is a complex, wide-ranging, and often debilitating condition that contributes to chronic pain. Caused by a number of different factors and contributors, the condition most commonly involves disease, chronic condition, or injury to the nervous system.
Defined by the International Association for the Study of Pain (IASP) as pain that occurs as a direct consequence of a lesion or disease affecting the somatosensory system, NP is responsible for 20 to 25% of patients who experience chronic pain and is estimated to affect 8% of the population.
While there have been significant improvements in pharmacological and nonpharmacological treatment for NP, these practices only provide consistent and lasting pain relief to a small percentage of patients. Recently regenerative medicine, also known as stem cell therapy, is being explored as a safe and effective NP therapy option.
In this review, Joshi et al. explore the possibilities of using stem cells in NP patients and discuss the relevant challenges associated with their uses in this application.
After identifying and defining the nine most common conditions associated with chronic, persistent, or recurring NP, the authors begin this review by pointing out that NP, to date, has been poorly recognized, poorly diagnosed, and poorly treated. A review of relevant literature has also demonstrated that the treatment of NP has consistently been a significant challenge for physicians, with most attempting to manage NP by targeting clinical symptoms rather than causative factors.
Most often, pharmacological treatment approaches for managing NP have included a variety of first-line drugs (tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and gabapentinoids) and opioid analgesics (tramadol) as second-line drugs. Third-line pharmacological NP treatment includes stronger opioids, such as morphine and oxycodone. Nonpharmacological NP treatment options for drug-refractory NP include interventional therapies (peripheral nerve blockade and epidural steroid injection), physical therapies (massage and ultrasound), and psychological therapies (cognitive behavioral therapy).
Long believed to arise from neurons, recent studies have demonstrated the important role of immune system response in the development of NP. Specifically, immune cells were found not only to be the source of pain mediators but also to produce analgesic molecules. These findings led researchers to believe that neutrophils and macrophages could each have a major role in early NP development.
Research has indicated that nerve injuries trigger an organized series of events to mount an inflammatory response. As part of this response to injury, pain following nerve damage has been shown to be mitigated by cytotoxic natural killer cells that selectively clear out partially damaged nerves. Additionally, this research has increasingly demonstrated that the immune system interacts with the sensory nervous system, contributing to persistent pain states.
Pharmacological and nonpharmacological treatment approaches have only produced temporary pain relief in patients with NP. Recently, stem cell transplantation has demonstrated significant potential for repairing nerve damage in NP and has emerged as a potential alternative therapeutic treatment approach. While the exact mechanism underlying stem cell-mediated pain relief remains unclear, specific stem cells (human mesenchymal stem cells, or hMSCs) have demonstrated the potential to provide trophic factors to the injured nerve as well as the ability to replace injured or lost neural cells.
While stem cell-based therapies have been shown to protect against neurodegeneration and promote neuroregeneration, the authors point out several issues that need to be addressed. These outstanding issues include identifying the optimal dosing for stem cell transplantation in the treatment of NP, sourcing of stem cells, considerations of autologous versus allogeneic transplants, precommitment to neuronal lineage, and specific dosing requirements.
Joshi et al. conclude that while NP is a chronic heterogeneous condition of the sensory nervous system with no current curative treatment, stem cells present exciting therapeutic prospects for NP. While further research to understand the exact mechanism underlying stem cell-mediated pain relief is required, current literature provides evidence of the potential of stem cells in slowing the degeneration process while promoting the survival and recovery of damaged nerves.
Source: Stem Cell Therapy for Modulating Neuroinflammation in … – NCBI.” 3 May. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124149/.
by Stemedix | May 29, 2023 | COPD
In this article, we are going to outline exactly what COPD is and the best treatment for COPD. COPD stands for chronic obstructive pulmonary disease. It is a chronic respiratory disease characterized by persistent airflow limitation that makes it difficult to breathe properly. COPD primarily affects the lungs and is usually caused by long-term exposure to irritating substances such as cigarette smoke, air pollution, and occupational dust and chemicals.
The two main conditions included under the umbrella term COPD are chronic bronchitis and emphysema:
Chronic bronchitis: This condition involves inflammation and narrowing of the airways, leading to increased production of mucus and persistent cough. Coughing and excessive mucus production typically last for at least three months per year for two consecutive years.
Emphysema: This condition involves damage to the air sacs (alveoli) in the lungs, which results in the loss of their elasticity. As a result, the air sacs are unable to fully deflate, leading to difficulty in exhaling air. This leads to air trapping in the lungs and reduced oxygen exchange.
The common symptoms of COPD include shortness of breath, chronic cough, wheezing, chest tightness, and increased mucus production. These symptoms tend to worsen over time, especially with continued exposure to respiratory irritants. COPD is a progressive disease, meaning it gradually worsens over time and can significantly impact a person’s quality of life.
Diagnosis of COPD typically involves a combination of medical history evaluation, physical examination, lung function tests (such as spirometry), and imaging tests like chest X-rays or CT scans. Early detection and diagnosis are crucial for effective management and treatment.
What Treatments Help Manage COPD?
The best treatment for chronic obstructive pulmonary disease (COPD) depends on the individual’s specific condition and its severity. COPD is a chronic respiratory disease characterized by airflow limitation and includes conditions such as chronic bronchitis and emphysema. While there is no cure for COPD, various treatment options are available to manage symptoms, improve lung function, and enhance overall quality of life. Here are some commonly used treatments:
- Medications: Bronchodilators are frequently prescribed to relax the muscles around the airways, making breathing easier. They can be short-acting or long-acting, and examples include beta-agonists and anticholinergics. Inhaled corticosteroids may be used to reduce airway inflammation in some cases.
- Oxygen therapy: Supplemental oxygen may be necessary if blood oxygen levels are low. Oxygen can be administered through nasal prongs, masks, or portable devices, as prescribed by a healthcare professional.
- Pulmonary rehabilitation: This is a structured program that combines exercise training, breathing techniques, and education to improve lung function, increase exercise tolerance, and enhance quality of life. It may involve a team of healthcare professionals, such as physiotherapists, respiratory therapists, and dietitians.
- Lifestyle changes: Quitting smoking is vital for slowing the progression of COPD. Avoiding exposure to environmental irritants, such as secondhand smoke and air pollution, is also important. Eating a healthy diet, staying physically active (within one’s limitations), and maintaining a healthy weight can support overall lung health.
- Vaccinations: Annual flu vaccinations are recommended for individuals with COPD to prevent respiratory infections. The pneumococcal vaccine is also advised to protect against certain strains of pneumonia.
- Surgical interventions: In severe cases of COPD, surgical options like lung volume reduction surgery (LVRS) or lung transplantation may be considered. These options are typically reserved for carefully selected individuals who meet specific criteria.
It is crucial for individuals with COPD to work closely with their healthcare providers to develop an individualized treatment plan based on their specific needs and circumstances. Regular follow-up appointments and adherence to the prescribed treatment are essential for effective management of COPD.
Regenerative Medicine for COPD
Regenerative medicine is a new area of medicine that holds potential in the field of COPD research and treatment. Regenerative medicine, also known as stem cell therapy, aims to restore, repair, or replace damaged tissues. While regenerative medicine is not currently considered traditional treatment for COPD, here are some ways it may potentially contribute to COPD management:
Stem cell therapy: Stem cells have the ability to develop into different types of cells in the body. Researchers are exploring the use of stem cell therapy, particularly mesenchymal stem cells (MSCs), as a potential treatment for COPD. MSCs have shown promise in reducing inflammation and promoting tissue repair in preclinical and early clinical studies. These stem cells can be derived from different sources, such as bone marrow or adipose tissue, and can be delivered directly into the lungs or systemically.
Mesenchymal stem cell (MSC) therapy is a potential regenerative medicine approach. MSCs are a type of adult stem cell that can differentiate into various cell types, possess anti-inflammatory properties, and have the ability to modulate the immune response. These characteristics make them attractive for potential therapeutic applications in COPD. Here’s an overview of MSC therapy for COPD:
- Mechanisms of action: MSCs have shown several mechanisms of action that can potentially benefit individuals with COPD. They can reduce inflammation in the lungs, promote tissue repair and regeneration, modulate immune responses, and secrete factors that can enhance the local environment and support healing.
- Sources of MSCs: MSCs can be derived from various sources, including bone marrow, adipose tissue (fat), umbilical cord tissue, and other tissues. Each source has its advantages and disadvantages, and research is ongoing to determine the most effective and safe sources of MSCs for COPD treatment.
- Administration of MSCs: MSCs can be delivered to the lungs through different routes, including intravenous (IV) infusion, inhalation, or direct injection into the lung tissue.
- Research and clinical trials: Preclinical studies and early-phase clinical trials have demonstrated some promising results for MSC therapy in COPD. These studies have shown improvements in lung function, reduction in inflammation, decreased airway remodeling, and enhanced exercise capacity.
While there is no cure for COPD, various treatment options are available to relieve symptoms, slow disease progression, and improve quality of life. These treatments often involve a combination of medications, pulmonary rehabilitation, oxygen therapy, and lifestyle modifications such as smoking cessation and avoiding respiratory irritants.
It is important for individuals with COPD to work closely with healthcare professionals to develop a personalized treatment plan and regularly monitor their condition to effectively manage COPD and minimize its impact on daily life.
by admin | May 26, 2023 | Health Awareness, Chronic Pain
Many health conditions and lifestyle factors lead to ongoing inflammation within the body. When you have widespread inflammation, it can lead to chronic pain, aches, and other health concerns.
If you want to lower inflammation and feel better overall, you may benefit from an anti-inflammatory diet. Learn more about the anti-inflammatory diet and what it includes below.
The Anti-Inflammatory Diet
While certain foods can trigger inflammation, others can reduce it. The anti-inflammatory diet limits inflammatory triggers and focuses primarily on foods that can lower inflammation.
Foods that Trigger Inflammation
Anti-inflammatory diets limit the following foods that are considered inflammation triggers:
- Red meat
- Processed foods
- Sugar
- Fried foods
- White bread
- Cookies, candy, and ice cream
- High sodium foods
- Alcohol
When these foods are highly restricted or altogether eliminated, it can lead to lower inflammation levels throughout the body.
Foods that Reduce Inflammation
While the anti-inflammatory diet restricts foods that are triggered, it calls for an increase in foods that can reduce inflammation. These foods include:
- Oily fish (tuna, salmon)
- Berries
- Green leafy vegetables
- Nuts and seeds
- Beans
- Olive oil
- Probiotics
- Tea
These anti-inflammatory foods are high in antioxidants and other properties that can decrease inflammation. When your diet consists mostly of these foods, you can see a significant reduction in widespread inflammation, which may lead to a resolution of chronic pain and other symptoms.
Starting an Anti-Inflammatory Diet
If you struggle with chronic inflammation and want to try the anti-inflammatory diet, always speak with your medical team beforehand. Making major dietary changes is very impactful and should be discussed with your doctor in advance.
It is important to make sure that the anti-inflammatory diet is a healthy fit for any underlying conditions you already have. It is also important to ensure you are healthy enough to make a major dietary change.
by admin | May 24, 2023 | Stem Cell Therapy, Mesenchymal Stem Cells, Stem Cell Research, Stroke
With nearly 15 million people affected worldwide each year, stroke continues to be the most prevalent cerebrovascular disease. Responsible for over 5 million deaths and another 5 million individuals suffering long-term disabilities, stroke also is the leading cause of mortality and morbidity worldwide.
Although there have been significant advances in both pharmacological and surgical therapies designed to treat the effects of stroke, effective therapy remains limited and primarily focused on managing the symptoms associated with a stroke rather than treating the causing factors or preventing the stroke at the onset.
Recently regenerative medicine, also known as stem cell therapy, and specifically mesenchymal stem cell (MSC)-based therapy has been identified as a potentially effective strategy for a wide range of diseases and health conditions, including stroke.
In this review, Li et al. examine current preclinical and clinical data from trials using MSCs in the treatment of stroke, the mechanisms underlying MSC-based therapy for stroke, and the challenges associated with the timing and delivery of MSCs.
Initial preclinical studies of the application of MSCs in the treatment of stroke demonstrated that transplantation of MSCs following ischemic stroke promoted improvement of cerebral function protected the ischemic neurons, and repaired brain damage. However, these studies were conducted in young and healthy subjects and failed to factor in the presence of comorbidities, such as diabetes and hypertension, more commonly observed in ischemic stroke patients.
Considering that 75% of strokes occur in the elderly and/or those with the previously mentioned comorbidities, the authors of this review focused their review on studies that incorporated these two factors into their trials.
While these preclinical studies of MSC-based therapy for stroke demonstrated promising results, including improved blood-brain barrier integrity, increased white matter remodeling, and improved neural repair, the authors point out that there has been a limited number of preclinical studies conducted and call for additional preclinical studies specifically utilizing the comorbidity model.
Although treatment of stroke using MSCs has been established to be safe and feasible in phase I and II clinical trials, there have been mixed findings as to the therapy’s efficacy. As a result of these varied findings, the overall efficacy in the treatment of ischemic stroke remains controversial. The authors consider several reasons for the inconsistency of results observed in these trials, including the varied number of patients, doses, and type of cell delivery, the timing of the cell therapy, and the treatment modalities used in these trials; the authors also call attention to the different locations, extent, and severity of lesions used in these trials.
As a result of the inconclusive results surrounding the effectiveness of MSC-based therapy for the treatment of stroke in these clinical trials, the authors call for more optimized and well-designed large-sample multicenter studies to evaluate the therapeutic efficacy of MSCs more thoroughly in ischemic stroke.
While the underlying mechanisms of MSC-based therapy for stroke have not been fully explained or understood, a review of several studies has demonstrated that MSCs protect against stroke through multiple mechanisms, including direct differentiation, paracrine effects, and mitochondrial transfer.
Before MSCs can be widely applied in clinical practice, Li et al. highlight several challenges that need to first be considered. These challenges include determining the optimal time for MSC administration during the acute stroke stages, further understanding the best treatment, conditions, and strategies to maximize the regenerative potential of MSCs, identifying the simplest and safest route of MSC delivery, and identifying the best source of MSCs for stroke treatment.
The authors conclude this review by recommending future preclinical and clinical studies that consider the adoption of a well-designed randomized controlled study design and method rigor and intervention measures to determine the effect of MSC therapy in the treatment of stroke.
Even with considering the above recommendations, MSCs continue to demonstrate exciting potential as a means to protect neurons and improve outcomes and overall quality of life for stroke patients.
Source: “Mesenchymal Stem Cell-Based Therapy for Stroke – NCBI.” 9 Feb. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899984/.
St. Petersburg, Florida
